- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging concepts in PD-1 checkpoint biology
Authors
Keywords
PD-1 pathway, Cancer immunotherapy, Immune regulation, Neoadjuvant, T cell exhaustion
Journal
SEMINARS IN IMMUNOLOGY
Volume -, Issue -, Pages 101480
Publisher
Elsevier BV
Online
2021-05-16
DOI
10.1016/j.smim.2021.101480
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damage
- (2021) Jonathan B. Johnnidis et al. Science Immunology
- Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
- (2021) Javid Moslehi et al. JOURNAL OF CLINICAL INVESTIGATION
- Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
- (2021) Kristen E. Pauken et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells
- (2021) Liliana E. Lucca et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
- (2021) E. A. Rozeman et al. NATURE MEDICINE
- Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
- (2021) Alexander M. Menzies et al. NATURE MEDICINE
- Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in lung cancer
- (2021) Paul Gueguen et al. Science Immunology
- Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
- (2020) Shugeng Gao et al. Journal of Thoracic Oncology
- Peripheral T cell expansion predicts tumour infiltration and clinical response
- (2020) Thomas D. Wu et al. NATURE
- ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
- (2020) John Alec Moral et al. NATURE
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection
- (2020) Se Jin Im et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
- (2020) Rita Nanda et al. JAMA Oncology
- Secreted BMP antagonists and their role in cancer and bone metastases
- (2020) Grace M. Todd et al. BONE
- Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
- (2020) Jean-Christophe Beltra et al. IMMUNITY
- Minimal PD-1 expression in mouse and human NK cells under diverse conditions
- (2020) Sean J. Judge et al. JOURNAL OF CLINICAL INVESTIGATION
- Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
- (2020) Catherine A Shu et al. LANCET ONCOLOGY
- PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
- (2020) Brian Diskin et al. NATURE IMMUNOLOGY
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
- (2020) Myriam Chalabi et al. NATURE MEDICINE
- Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
- (2020) Maud Mayoux et al. Science Translational Medicine
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- PD-1: Its Discovery, Involvement in Cancer Immunotherapy, and Beyond
- (2020) Yasumasa Ishida Cells
- IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma
- (2020) Joe-Marc Chauvin et al. CLINICAL CANCER RESEARCH
- Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune complex
- (2020) Sarah C. Garrett-Thomson et al. PLoS One
- The PD-1 Pathway Regulates Development and Function of Memory CD8+ T Cells following Respiratory Viral Infection
- (2020) Kristen E. Pauken et al. Cell Reports
- The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
- (2020) Floris Dammeijer et al. CANCER CELL
- PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
- (2020) Catherine L. Tan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
- (2020) Yang Gao et al. NATURE CELL BIOLOGY
- Early precursor T cells establish and propagate T cell exhaustion in chronic infection
- (2020) Daniel T. Utzschneider et al. NATURE IMMUNOLOGY
- The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
- (2020) Shogo Kumagai et al. NATURE IMMUNOLOGY
- Tolerance in the Age of Immunotherapy
- (2020) Jeffrey A. Bluestone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
- (2020) Joshua E Reuss et al. Journal for ImmunoTherapy of Cancer
- Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
- (2020) J. Bryan Iorgulescu et al. CLINICAL CANCER RESEARCH
- Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
- (2019) Sema Kurtulus et al. IMMUNITY
- Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
- (2019) Imran Siddiqui et al. IMMUNITY
- A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
- (2019) Alexander C. Huang et al. NATURE MEDICINE
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
- (2019) Kurt A. Schalper et al. NATURE MEDICINE
- Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
- (2019) Brian C. Miller et al. NATURE IMMUNOLOGY
- PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua
- (2019) Paola Vacca et al. Mucosal Immunology
- Blockade of RGMb inhibits allergen-induced airways disease
- (2019) Sanhong Yu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD‐1 receptor
- (2019) Nicola Tumino et al. INTERNATIONAL JOURNAL OF CANCER
- T follicular regulatory (Tfr) cells: Dissecting the complexity of Tfr‐cell compartments
- (2019) Válter R. Fonseca et al. IMMUNOLOGICAL REVIEWS
- Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?
- (2019) Anna S. Berghoff et al. Nature Reviews Neurology
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses
- (2019) Daisuke Sugiura et al. SCIENCE
- Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
- (2019) Elisa A Rozeman et al. LANCET ONCOLOGY
- Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection
- (2019) Chen Yao et al. NATURE IMMUNOLOGY
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4
- (2019) Takashi Sekiya et al. Scientific Reports
- The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy
- (2019) Erich Sabio et al. Genome Medicine
- Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions
- (2019) Francesca Romana Mariotti et al. Frontiers in Immunology
- PD-1hi CD8+ resident memory T cells balance immunity and fibrotic sequelae
- (2019) Zheng Wang et al. Science Immunology
- PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity
- (2019) Jianshu Wei et al. Journal for ImmunoTherapy of Cancer
- TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision
- (2019) Zeyu Chen et al. IMMUNITY
- Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
- (2019) Thomas Powles et al. NATURE MEDICINE
- Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
- (2019) Spencer C. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy
- (2019) Jiajing Cai et al. OncoTargets and Therapy
- PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
- (2019) Yunlong Zhao et al. IMMUNITY
- Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection
- (2019) William H. Hudson et al. IMMUNITY
- Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?
- (2019) Víctor A. Arrieta et al. JOURNAL OF NEUROSURGERY
- An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
- (2019) Caroline S. Jansen et al. NATURE
- Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
- (2018) Rodabe N Amaria et al. LANCET ONCOLOGY
- Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the lung airways and parenchyma
- (2018) Sean R. McMaster et al. Mucosal Immunology
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
- (2018) Xinyi Guo et al. NATURE MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of PD-1 during effector CD8 T cell differentiation
- (2018) Eunseon Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Epigenetic regulators of programmed death-ligand 1 expression in human cancers
- (2018) Sachin Kumar et al. Translational Research
- Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
- (2018) Yunlong Zhao et al. Cell Reports
- PD-L1 binds to B7-1 only in cis on the same cell surface
- (2018) Apoorvi Chaudhri et al. Cancer Immunology Research
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- High-dimensional single cell analysis identifies stem-like cytotoxic CD8+T cells infiltrating human tumors
- (2018) Jolanda Brummelman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
- (2018) Rodabe N. Amaria et al. NATURE MEDICINE
- Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
- (2018) Christian U. Blank et al. NATURE MEDICINE
- Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
- (2018) Elena Gianchecchi et al. Frontiers in Immunology
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-1 regulates KLRG1+group 2 innate lymphoid cells
- (2017) Samuel Taylor et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Chromatin states define tumour-specific T cell dysfunction and reprogramming
- (2017) Mary Philip et al. NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
- (2017) Alice O. Kamphorst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exhaustion-associated regulatory regions in CD8+tumor-infiltrating T cells
- (2017) Giuliana P. Mognol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- RGMs: Structural Insights, Molecular Regulation, and Downstream Signaling
- (2017) Christian Siebold et al. TRENDS IN CELL BIOLOGY
- Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy
- (2017) Eszter Lázár-Molnár et al. EBioMedicine
- T Cell Factor 1-Expressing Memory-like CD8 + T Cells Sustain the Immune Response to Chronic Viral Infections
- (2016) Daniel T. Utzschneider et al. IMMUNITY
- Dynamic Changes in Chromatin Accessibility Occur in CD8 + T Cells Responding to Viral Infection
- (2016) James P. Scott-Browne et al. IMMUNITY
- T follicular regulatory cells
- (2016) Peter T. Sage et al. IMMUNOLOGICAL REVIEWS
- What does PD-L1 positive or negative mean?
- (2016) Antoni Ribas et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genetic and Epigenetic Regulation of PD-1 Expression
- (2016) Alexander P. R. Bally et al. JOURNAL OF IMMUNOLOGY
- Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection
- (2016) Ran He et al. NATURE
- Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway
- (2016) Yong Yu et al. NATURE
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles
- (2016) Yew Ann Leong et al. NATURE IMMUNOLOGY
- The epigenetic landscape of T cell exhaustion
- (2016) D. R. Sen et al. SCIENCE
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer
- (2016) Jin Li et al. Oncotarget
- Deciphering the Innate Lymphoid Cell Transcriptional Program
- (2016) Cyril Seillet et al. Cell Reports
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
- (2015) Sonja Kleffel et al. CELL
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+T cells
- (2015) Pamela M. Odorizzi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tissue-Resident Memory T Cells and Fixed Immune Surveillance in Nonlymphoid Organs
- (2015) Francis R. Carbone JOURNAL OF IMMUNOLOGY
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma
- (2015) S. Derks et al. Cancer Immunology Research
- PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
- (2015) K. M. Mahoney et al. Cancer Immunology Research
- Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
- (2015) Roberto Bellucci et al. OncoImmunology
- Autocrine activation of canonical BMP signaling regulates PD-L1 and PD-L2 expression in human dendritic cells
- (2014) Víctor G. Martínez et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues
- (2014) Tetsuya Honda et al. IMMUNITY
- Epitope-Specific Regulation of Memory Programming by Differential Duration of Antigen Presentation to Influenza-Specific CD8+ T Cells
- (2014) André Ballesteros-Tato et al. IMMUNITY
- Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection
- (2014) Peiyuan Lu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
- (2014) Yanping Xiao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular regulation of effector and memory T cell differentiation
- (2014) John T Chang et al. NATURE IMMUNOLOGY
- A Soluble Form of CD80 Enhances Antitumor Immunity by Neutralizing Programmed Death Ligand-1 and Simultaneously Providing Costimulation
- (2014) S. T. Haile et al. Cancer Immunology Research
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Structure and Interactions of the Human Programmed Cell Death 1 Receptor
- (2013) Xiaoxiao Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis
- (2013) Bernd H. Zinselmeyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Soluble CD80 Restores T Cell Activation and Overcomes Tumor Cell Programmed Death Ligand 1-Mediated Immune Suppression
- (2013) S. T. Haile et al. JOURNAL OF IMMUNOLOGY
- Lung-resident memory CD8 T cells (TRM ) are indispensable for optimal cross-protection against pulmonary virus infection
- (2013) Tao Wu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Disparate Individual Fates Compose Robust CD8+ T Cell Immunity
- (2013) V. R. Buchholz et al. SCIENCE
- Heterogeneous Differentiation Patterns of Individual CD8+ T Cells
- (2013) C. Gerlach et al. SCIENCE
- Low-Affinity T Cells Are Programmed to Maintain Normal Primary Responses but Are Impaired in Their Recall to Low-Affinity Ligands
- (2013) Karin M. Knudson et al. Cell Reports
- Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling
- (2012) Jin Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Viral acute lower respiratory infections impair CD8+ T cells through PD-1
- (2012) John J. Erickson et al. JOURNAL OF CLINICAL INVESTIGATION
- Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
- (2012) Helge Frebel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
- (2012) M. A. Paley et al. SCIENCE
- Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation
- (2012) N. Patsoukis et al. Science Signaling
- The role of the PD-1 pathway in autoimmunity and peripheral tolerance
- (2011) Brian T. Fife et al. Annals of the New York Academy of Sciences
- Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells
- (2011) Ben Youngblood et al. IMMUNITY
- Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80
- (2011) S. T. Haile et al. JOURNAL OF IMMUNOLOGY
- The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
- (2011) A. M. Paterson et al. JOURNAL OF IMMUNOLOGY
- Programmed Death 1 Regulates Development of Central Memory CD8 T Cells after Acute Viral Infection
- (2011) S. R. Allie et al. JOURNAL OF IMMUNOLOGY
- The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo
- (2011) J. Yang et al. JOURNAL OF IMMUNOLOGY
- Environmental and Antigen Receptor-Derived Signals Support Sustained Surveillance of the Lungs by Pathogen-Specific Cytotoxic T Lymphocytes
- (2011) Y.-T. Lee et al. JOURNAL OF VIROLOGY
- PD-L2 is predominantly expressed by Th2 cells
- (2011) W. Joost Lesterhuis et al. MOLECULAR IMMUNOLOGY
- PD-L2 is expressed on activated human T cells and regulates their function
- (2011) Nassima Messal et al. MOLECULAR IMMUNOLOGY
- B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
- (2010) J.-J. Park et al. BLOOD
- PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
- (2010) M. Ghiotto et al. INTERNATIONAL IMMUNOLOGY
- Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines
- (2010) Emanuela Romano et al. JOURNAL OF CLINICAL ONCOLOGY
- Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection
- (2010) Taeg S. Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The route of priming influences the ability of respiratory virus–specific memory CD8+T cells to be activated by residual antigen
- (2010) Shiki Takamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dynamic Equilibrium of B7-1 Dimers and Monomers Differentially Affects Immunological Synapse Formation and T Cell Activation in Response to TCR/CD28 Stimulation
- (2010) Sumeena Bhatia et al. JOURNAL OF IMMUNOLOGY
- Dragon (Repulsive Guidance Molecule b) Inhibits IL-6 Expression in Macrophages
- (2010) Y. Xia et al. JOURNAL OF IMMUNOLOGY
- CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition
- (2010) D. L. Barber et al. JOURNAL OF IMMUNOLOGY
- PD-1 on dendritic cells impedes innate immunity against bacterial infection
- (2009) S. Yao et al. BLOOD
- The RGM/DRAGON family of BMP co-receptors
- (2009) Elena Corradini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- TGF-β Superfamily Signaling in Embryonic Development and Homeostasis
- (2009) Mary Y. Wu et al. DEVELOPMENTAL CELL
- Diversity in T Cell Memory: An Embarrassment of Riches
- (2009) Stephen C. Jameson et al. IMMUNITY
- Recall Responses by Helpless Memory CD8+ T Cells Are Restricted by the Up-Regulation of PD-1
- (2009) S. Fuse et al. JOURNAL OF IMMUNOLOGY
- Target-Dependent B7-H1 Regulation Contributes to Clearance of Central Nervous Sysyem Infection and Dampens Morbidity
- (2009) T. W. Phares et al. JOURNAL OF IMMUNOLOGY
- RGMb controls aggregation and migration of Neogenin-positive cells in vitro and in vivo
- (2009) Sabine Conrad et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
- (2009) Brian T Fife et al. NATURE IMMUNOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Interaction of human PD-L1 and B7-1
- (2008) Manish J. Butte et al. MOLECULAR IMMUNOLOGY
- Structures of PD-1 with its ligands: Sideways and dancing cheek to cheek
- (2008) G. J. Freeman PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum
- (2008) E. Lazar-Molnar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective expansion of a subset of exhausted CD8 T cells by PD-L1 blockade
- (2008) S. D. Blackburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search